MolecularMD Announces Three Presentations Highlighting Non-Invasive Biomarker Detection and NGS Validation at Upcoming Scientific Conferences
24 oct. 2012 08h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - Oct 24, 2012) - MolecularMD Corp. announced today that presentations pertaining to clinical validation of Next Generation Sequencing platforms and advances in...
MolecularMD Submits Premarketing Approval Application to the FDA for Its BCR-ABL T315I Mutation Test, a Companion Diagnostic to Ponatinib, an Investigational BCR-ABL Inhibitor
30 juil. 2012 16h05 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - Jul 30, 2012) - MolecularMD Corp. today announced that it has submitted its application for Premarket Approval (PMA) of the MolecularMD BCR-ABL T315I Mutation Test...
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
02 avr. 2012 08h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - Apr 2, 2012) - MolecularMD Corp. announces that it has closed a $6 Million Series B equity financing led by existing investor, Ballast Point Ventures, which is joined by...
MolecularMD Announces Issuance of Patent Covering Methods for Therapeutic Resistance Monitoring in Lung Cancer Patients
09 déc. 2011 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - Dec 9, 2011) - MolecularMD Corp. today announces the issuance of a patent titled "Methods and Compositions for Detecting a Drug Resistant EGFR Mutant." The newly issued...
MolecularMD Corp. Obtains Exclusive License From NYU and MSKCC for BRAF Melanoma Assay
18 oct. 2010 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - October 18, 2010) - MolecularMD Corp. announced today that it has entered into a licensing agreement with New York University (NYU) and Memorial Sloan-Kettering Cancer...
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
28 oct. 2009 07h00 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - October 28, 2009) - MolecularMD Corp announced today that it has
moved their core operations to a expanded dedicated facility with capacity
and functionality to support...